HW
ABBV icon

Hedeker Wealth’s AbbVie ABBV Stock Holding History

Hedeker Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,719
Closed -$861K – 88
2025
Q3 		$861K Buy
3,719
+50
+1% +$10.2K 0.18% 75
2025
Q2 		$681K Buy
3,669
+2,686
+273% +$499K 0.16% 76
2025
Q1 		$206K Buy
+983
New +$191K 0.06% 87
2023
Q3 		– Sell
-17,161
Closed -$2.31M – 85
2023
Q2 		$2.31M Sell
17,161
-414
-2% -$60.7K 0.77% 53
2023
Q1 		$2.8M Sell
17,575
-1,006
-5% -$154K 1% 48
2022
Q4 		$3M Buy
18,581
+50
+0.3% +$7.67K 1.12% 40
2022
Q3 		$2.49M Sell
18,531
-2,696
-13% -$387K 0.97% 46
2022
Q2 		$3.2M Buy
21,227
+2,130
+11% +$325K 1.1% 32
2022
Q1 		$3.1M Sell
19,097
-4,114
-18% -$598K 0.94% 45
2021
Q4 		$3.14M Sell
23,211
-3,033
-12% -$358K 0.91% 45
2021
Q3 		$2.83M Buy
26,244
+3,966
+18% +$453K 0.87% 44
2021
Q2 		$2.51M Buy
22,278
+1,036
+5% +$117K 0.78% 49
2021
Q1 		$2.3M Sell
21,242
-16
-0.1% -$1.71K 0.81% 47
2020
Q4 		$2.28M Sell
21,258
-730
-3% -$70.2K 0.8% 46
2020
Q3 		$1.93M Buy
21,988
+16,193
+279% +$1.52M 0.91% 49
2020
Q2 		$568K Buy
+5,795
New +$510K 0.29% 58
2016
Q4 		– Sell
-1,864
Closed -$29.6K – 117
2016
Q3 		$29.6K Sell
1,864
-27,469
-94% -$1.78M 1.53% 20
2016
Q2 		$1.82M Buy
29,333
+255
+0.9% +$15.5K 1.59% 15
2016
Q1 		$1.66M Buy
29,078
+276
+1% +$15.4K 1.56% 28
2015
Q4 		$1.71M Buy
28,802
+219
+0.8% +$12.6K 1.51% 25
2015
Q3 		$1.55M Buy
28,583
+191
+0.7% +$12.4K 1.35% 28
2015
Q2 		$1.91M Buy
28,392
+201
+0.7% +$13.1K 1.53% 26
2015
Q1 		$1.81M Buy
28,191
+215
+0.8% +$13K 1.5% 27
2014
Q4 		$1.83M Buy
+27,976
New +$1.76M 1.48% 29

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Hedeker Wealth's ABBV Position: Q4 2025 in Review

Hedeker Wealth sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 3,719 shares — an estimated $861K sold.

Hedeker Wealth first reported a position in ABBV in Q4 2014 and held it in 24 quarters. The position peaked at $3.2M in Q2 2022. 4,147 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Hedeker Wealth reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Hedeker Wealth sold 3,719 AbbVie shares in Q4 2025, an estimated $861K.
  • Hedeker Wealth first reported a position in AbbVie in Q4 2014 and held it in 24 quarters.
  • Hedeker Wealth's AbbVie position peaked at $3.2M in Q2 2022.
  • 4,147 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Hedeker Wealth's 13F filing for Q4 2025, filed 23 Jan 2026.